Aspen Aerogels, Inc. filings document the company's aerogel technology business, operating results and material corporate events. Recent Forms 8-K cover quarterly and annual financial results, Regulation FD disclosures, business developments, manufacturing-facility updates, and amendments to the MidCap Loan Facility and related credit-party obligations.
The filing record also includes proxy materials describing governance, board and compensation matters, executive employment arrangements, equity awards and shareholder voting items. Aspen's disclosures connect its capital structure and credit covenants with operations in Energy Industrial and Thermal Barrier products, including PyroThin, Cryogel and Pyrogel applications.
Aspen Aerogels, Inc. common stock is reported as beneficially owned by Orin Hirschman and AIGH Capital Management LLC. Each reports 7,150,126 shares, equal to 8.6% of the class, with sole voting and dispositive power over that amount and zero shared voting or dispositive power. Hirschman is identified as managing member of AIGH Capital Management LLC and president of AIGH Investment Partners LLC.
Aspen Aerogels Inc. (ASPN) reported that 1,143 of CAO, GC & Corp Secretary Glenn E. Deegan’s Common Stock shares were withheld on September 30, 2026, to satisfy minimum statutory tax withholding requirements on vesting of RSUs. His reported post-transaction position comprised 2,748 Common Stock shares and 63,285 RSUs.
Aspen Aerogels, Inc. (ASPN) is the issuer covered by a report in which Wood River Capital, LLC and Koch, Inc., identified as the reporting persons, state that 12,280,426 Public Shares were sold on September 23, 2026, at $4.73 per share in a block trade. They state that they held no Public Shares as of that date and had ceased to be beneficial owners of any Public Shares. They also report no present plans or proposals relating to the specified corporate actions.
Aspen Aerogels Inc. (ASPN) reported that Wood River Capital, LLC, identified as a former 10% owner, sold 12,280,426 common shares on September 23, 2026, at $4.73 per share in a single block trade. Wood River’s reported direct holdings after the sale were zero shares. A footnote says Koch Industries, Inc. and intermediate entities may be deemed beneficial owners of Wood River’s shares; Koch, Inc. is separately listed as a 10% owner. No Rule 10b5-1 plan is reported.
Aspen Aerogels, Inc. (ASPN) furnished an investor presentation outlining its business profile, growth drivers and financial targets. The company reports $202 million in last-twelve-month revenue through Q2 2026, with $111 million from Thermal Barrier and $92 million from Energy Industrial.
The presentation states existing manufacturing and external supply arrangements support $600+ million of annual revenue capacity and long-term targets of 35% gross margin and 25% Adjusted EBITDA margin. Management indicates the Adjusted EBITDA breakeven revenue target has fallen about 47% and targets breakeven at about $175 million annualized revenue by year-end 2027.
Guidance for Q3 2026 includes a net loss between $6.0 million and $9.0 million, but a return to positive Adjusted EBITDA between $7.0 million and $15.0 million. Aspen also highlights a portfolio of about 400 granted and over 430 pending patents and a cash and equivalents balance of $153, supporting recovery and growth plans.
Aspen Aerogels Inc. received an amended Schedule 13G filing from Needham Investment Management L.L.C., Needham Asset Management, LLC and George A. Needham reporting their holdings of the company’s common stock. The reporting group states beneficial ownership of 3,260,800 shares of common stock, representing 3.9% of the outstanding class.
All reported shares are held with shared voting and dispositive power, and no sole voting or dispositive power is reported by any of the filers. The securities are directly owned by advisory clients of Needham Investment Management L.L.C., and each reporting person disclaims beneficial ownership except to the extent of its or his pecuniary interest. The filing notes ownership of 5 percent or less of the class.
A shareholder of ASPN filed to sell common stock under Rule 144 through Morgan Stanley Smith Barney LLC Executive Financial Services. The filing covers 5,593 common shares with an aggregate market value of $35,291.83 to be sold on the NYSE.
The shares derive from restricted stock issued by the company, including 3,761 shares from a grant dated 09/13/2025 and 1,832 shares from a grant dated 03/05/2026. These entries are listed as securities to be sold, not new issuances.
Aspen Aerogels, Inc. reported significantly lower results for the quarter and six months ended June 30, 2026. Revenue declined to $49.8 million in Q2 and $87.7 million year‑to‑date, from $78.0 million and $156.7 million in the prior‑year periods, with both Thermal Barrier and Energy Industrial sales down.
Gross profit fell to $3.3 million for Q2 and $7.5 million year‑to‑date, and the company recorded net losses of $23.3 million in Q2 and $47.0 million for the first half, narrower than the prior year, which included large Statesboro plant impairment charges.
At June 30, 2026, Aspen held $151.7 million of cash and cash equivalents, generated $17.9 million of operating cash in the first half, and carried a $79.5 million term loan and $10.9 million drawn on its revolving facility. A $37.6 million settlement with a large Thermal Barrier customer is being recognized as revenue over about two years, contributing to $35.3 million of deferred revenue. The company also booked an $8.9 million loss on damaged assets and a matching insurance receivable from East Providence incidents, and stated that existing cash should support operations for at least twelve months, while long‑term growth is expected to require additional financing.
Aspen Aerogels reported second quarter 2026 revenue of $49.8 million, down from $78.0 million a year earlier, as Thermal Barrier and Energy Industrial sales declined year-over-year amid changes to North American EV regulatory frameworks. Thermal Barrier revenue was $29.5 million versus $55.2 million, while Energy Industrial revenue was $20.4 million versus $22.8 million. Net loss widened to $23.3 million (or $0.28 per share) from $9.1 million (or $0.11 per share), and Adjusted EBITDA moved to a loss of $(6.6) million from a profit of $9.7 million.
Results reflected an $8.9 million loss on property damage from the April 2026 East Providence incident, offset by an equal insurance recovery receivable, plus $5.3 million of other incident-related costs that Aspen plans to claim under business interruption coverage. Despite this disruption, total revenue grew 32% quarter-over-quarter and Thermal Barrier revenue increased 81% quarter-over-quarter, supported by stabilizing North American EV demand and European momentum. The company highlighted a PyroThin® award from Jaguar Land Rover for two next-generation vehicle architectures and ended the quarter with $153.4 million in cash, cash equivalents and restricted cash. For Q3 2026, Aspen guides to revenue of $65–$80 million, net loss of $6–$9 million, and positive Adjusted EBITDA of $7–$15 million, excluding an estimated $5–$10 million of additional incident-related costs.
Aspen Aerogels director William P. Noglows reported an option exercise and updated his holdings. He exercised stock options covering 14,799 shares of Common Stock at an exercise price of $4.75 per share, converting them into directly held shares.
After the transaction, he directly holds 114,156 shares of Common Stock, which the footnotes state includes 103,786 shares and 10,370 Restricted Stock Units. The filing also notes 10,000 shares held indirectly in a trust for each of two children, where he serves as trustee.